Format

Send to:

Choose Destination
See comment in PubMed Commons below
Paediatr Drugs. 2013 Apr;15(2):133-8. doi: 10.1007/s40272-013-0008-6.

Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.

Author information

  • 1Department of Dermatology, Yale University School of Medicine, P.O. Box 208059, New Haven, CT 06520, USA. brittany.craiglow@yale.edu

Abstract

Infantile hemangiomas (IH), benign vascular neoplasms, are the most common tumors of infancy and childhood. Most IH are medically insignificant; however, a proportion will require treatment because of interference with vital structures, threat of significant disfigurement, ulceration, or bleeding. This article reviews current and potential pharmacotherapeutic approaches to the treatment of IH. While corticosteroids have long been considered the mainstay of medical therapy for IH, several new treatments have recently emerged, the most promising of which is oral propranolol. Topical timolol and imiquimod are additional new therapies that may also prove to be effective, particularly for the treatment of superficial IH.

PMID:
23456550
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk